• Covid-19 How will the coronavirus change in the coming months?

    How will you act this winter?

  • Spain The incidence rises again more than one point to 43.15 cases

  • United Kingdom They propose to recover Covid restrictions for the winter

The coronavirus figures in Spain worsen, the cumulative incidence indicator (AI) this Wednesday stood at 43.15 cases per 100,000 inhabitants, after an increase of more than one point in the last day.

The same trend can be observed in the seven-day AI

, key to detect rapid trend changes, which also rises almost four points compared to Tuesday (23,19). This last figure, since it is less than 25, continues to corroborate that Spain is still a low-risk country in terms of Covid-19.

The autonomous communities have administered a total of 71,102,258 doses of the

coronavirus

vaccines

from Pfizer-BioNTech, Moderna, AstraZeneca and Janssen

until this Wednesday

, 29,997 of them in the last 24 hours.

This represents 94% of those distributed, which amount to 75,642,021 units.

The data of the coronavirus in Spain

Total figures

: 4,993,295 confirmed coronavirus cases with diagnostic test for active infection;

There have been 87,082 deaths with a positive test as of October 20.

  • 805,888 in Andalusia (11,244 dead)

  • 162,139 in Aragon (3,873 dead)

  • 71,145 in Asturias (2,072 dead)

  • 100,224 in the Balearic Islands (979 dead)

  • 96,373 in the Canary Islands (1,004 dead)

  • 46,629 in Cantabria (609 dead)

  • 239,630 in Castilla-La Mancha (6,477 dead)

  • 300,578 in Castilla y León (7,334 dead)

  • 926,093 in Catalonia (15,832 dead)

  • 7,578 in Ceuta (128 dead)

  • 513,090 in the Valencian Community (7,798 dead)

  • 103,041 in Extremadura (1,998 dead)

  • 187,133 in Galicia (2,645 dead)

  • 895,841 in Madrid (16,167 dead)

  • 11,054 in Melilla (111 dead)

  • 141,897 in Murcia (1,745 dead)

  • 83,010 in Navarra (1,251 dead)

  • 262,356 in the Basque Country (4,992 dead)

  • 39,596 in La Rioja (823 dead)

07.00 Pfizer's vaccine, highly effective in adolescents against the Delta variant of the coronavirus

The vaccine of the

Covid-19

of

Pfizer / BionTech

is highly effective in adolescents, according to

a study focused on the variant Delta the

SARS-CoV-2

and showing that in young fully vaccinated risk of symptomatic disease decreased by 93% compared with the unvaccinated.

The work is published in

The New England Journal of Medicine

with data on the adolescent population of Israel, and its manager is the Israeli Clalit Research Institute, in collaboration with Harvard University (United States).

According to the criteria of The Trust Project

Know more

  • Vaccines

  • Coronavirus

  • Covid 19

  • Science and Health

Covid-19Coronavirus, last minute |

Health reports 2,248 new cases and 57 deaths;

incidence remains at 40

Covid-19Coronavirus, last minute |

The Government announces that it will soon remove restrictions to access the terminals of Aena airports

Covid-19Vaccinate minors between 5 and 11 years old, between the priority and the need to reach 90% coverage in Spain

See links of interest

  • The Palm

  • Last News

  • What

  • Work calendar

  • Home THE WORLD TODAY

  • Master Investigation Journalism

  • The Hormiguero

  • Barcelona - Dinamo Kiev, live

  • FC Red Bull Salzburg - VfL Wolfsburg

  • Benfica - FC Bayern München

  • Chelsea - Malmö FF

  • Lille - Seville

Keywords: spain, ai, cases, pfizer, inhabitants, incidence indicator, adolescents, coronavirus, variant, vaccine, restrictions, increase, news, incidence, point